PUBLISHER: iData Research Inc. | PRODUCT CODE: 1667638
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1667638
The global benign prostatic hyperplasia (BPH) treatment device market was valued at over $1.0 billion in 2024 and is projected to grow at a CAGR of 5.1%, reaching over $1.4 billion by 2031.
Market Segments Covered:
* Monopolar Electrodes
* Bipolar Electrodes
* Holmium & Thulium Laser Equipment
* Holmium & Thulium Laser Fibers
Comprehensive Market Insights
Global BPH Treatment Device Market Trends
Market Share Insights
Top Competitors in the Global BPH Treatment Device Market (2024):
1 Teleflex
* Market leader, with a monopoly in the UroLift(R) segment.
2 Boston Scientific
* Dominant leader in the laser BPH market.
* Monopolistic position in the Rezum(R) market.
* Key Products: VersaPulse(TM) PowerSuite(TM) Holmium Laser, Lumenis Pulse(TM) Holmium Lasers (100W & 120W).
* Mergers & Acquisitions: Acquired Lumenis' global surgical business in 2021.
3 Olympus
Market Segmentation Summary
Key Market Segments:
Global Research Scope
Report Details:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
Quantitative Coverage:
Qualitative Coverage:
Data Sources:
Table of Contents
BPH Treatment Device Market
List of Charts
List of Figures